Cycloguanil hydrochloride

Overview

Cycloguanil (Chlorguanide triazine) hydrochloride is a dihydrofolate reductase ( DHFR ) inhibitor with an IC 50 of 10.8 μM against human DHFR . Cycloguanil hydrochloride blocks the folate metabolic pathway, thereby affecting nucleotide synthesis and interfering with DNA replication. Cycloguanil inhibits DHFR in Plasmodium and is thus used in malaria research. Cycloguanil hydrochloride also potently inhibits DHFR in human cancer cells and blocks the transcriptional activity of STAT3 , thereby exhibiting anticancer activity.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Infection | Products > Disease Areas > Breast Cancer | Products > Disease Areas > Parasitic Infection | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Anti-infection | Products > Signaling Pathways > Stem Cell/Wnt | Products > Signaling Pathways > JAK/STAT Signaling | Products > Research Areas > Infection | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Stem Cells | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Antifolate | Products > Signaling Pathways > Parasite | Products > Signaling Pathways > DNA/RNA Synthesis | Products > Signaling Pathways > STAT

Product Information

• Catalog No.: HY-12784A
• CAS No.: 152-53-4
• Molecular Formula: C11H15Cl2N5
• Molecular Weight: 288.18
• Purity: 99.93%
• Storage: 4°C, sealed storage, away from moisture * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
• Solubility: ≥ 2.08 mg/mL (7.22 mM); Clear solution
• Availability: In-stock

Source

Original product source